The model for end-stage liver disease (MELD) (Q28290440)

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

Europe PubMed Central

title

The model for end-stage liver disease (MELD) (English)

0 references

1 reference

end-stage liver disease

1 reference

Patrick S Kamath

1

0 references

W Ray Kim

series ordinal

2

0 references

language of work or name

English

0 references

publication date

March 2007

0 references

published in

Hepatology

0 references

volume

45

0 references

page(s)

797-805

0 references

issue

3

0 references

cites work

1 reference

7 January 2021

A model to predict survival in patients with end-stage liver disease

1 reference

7 January 2021

MELD and PELD: application of survival models to liver allocation

1 reference

7 January 2021

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

7 January 2021

Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list.

1 reference

7 January 2021

Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease

1 reference

7 January 2021

MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.

1 reference

7 January 2021

MELD: the holy grail of organ allocation?

1 reference

7 January 2021

MELD-based liver allocation: who is underserved?

1 reference

7 January 2021

The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution

1 reference

7 January 2021

Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements.

1 reference

7 January 2021

Model for end-stage liver disease (MELD) exception guidelines

1 reference

7 January 2021

Liver transplantation with the Meld system: a prospective study from a single European center

1 reference

7 January 2021

Liver transplant recipient selection: MELD vs. clinical judgment.

1 reference

7 January 2021

MELD and prediction of post-liver transplantation survival

1 reference

7 January 2021

Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States

1 reference

7 January 2021

Pretransplant MELD Score As a Predictor of Outcome After Liver Transplantation for Chronic Hepatitis C

1 reference

7 January 2021

Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model

1 reference

7 January 2021

Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation

1 reference

7 January 2021

Assignment of steatotic livers by the Mayo model for end-stage liver disease

1 reference

7 January 2021

Should donors and recipients be matched in liver transplantation?

1 reference

7 January 2021

The survival benefit of liver transplantation

1 reference

7 January 2021

Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores

1 reference

7 January 2021

Impact of recipient MELD score on resource utilization

1 reference

7 January 2021

An older liver in the hand, or a (possibly) younger liver in the bush?

1 reference

7 January 2021

An outcome comparison between primary liver transplantation and retransplantation based on the pretransplant MELD score

1 reference

7 January 2021

Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?

1 reference

7 January 2021

Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation

1 reference

7 January 2021

Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation.

1 reference

7 January 2021

Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy

1 reference

7 January 2021

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

1 reference

7 January 2021

Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B

1 reference

7 January 2021

1 reference

7 January 2021

Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding.

1 reference

7 January 2021

MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices

1 reference

7 January 2021

MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation

1 reference

7 January 2021

Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study

1 reference

7 January 2021

Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites.

1 reference

7 January 2021

MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients

1 reference

7 January 2021

Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes

1 reference

7 January 2021

MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis

1 reference

7 January 2021

MELD accurately predicts mortality in patients with alcoholic hepatitis

1 reference

7 January 2021

Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis

1 reference

7 January 2021

Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems

1 reference

7 January 2021

Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit

1 reference

7 January 2021

Effects of artificial liver support system on patients with acute or chronic liver failure.

1 reference

7 January 2021

The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

1 reference

7 January 2021

Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites

1 reference

7 January 2021

MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures

1 reference

7 January 2021

Evaluation of a model to predict poor survival in patients undergoing elective TIPS procedures

1 reference

7 January 2021

Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after

1 reference

7 January 2021

Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery.

1 reference

7 January 2021

Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality

1 reference

7 January 2021

Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis

1 reference

7 January 2021

Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores

1 reference

7 January 2021

The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome

1 reference

7 January 2021

Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis

1 reference

7 January 2021

Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis

1 reference

7 January 2021

Predictive indices of morbidity and mortality after liver resection

1 reference

7 January 2021

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

7 January 2021

Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis

1 reference

7 January 2021

Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?

1 reference

7 January 2021

Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?

1 reference

7 January 2021

Longitudinal assessment of mortality risk among candidates for liver transplantation

1 reference

7 January 2021

Serum sodium predicts mortality in patients listed for liver transplantation

1 reference

7 January 2021

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death

1 reference

7 January 2021

Evidence-based incorporation of serum sodium concentration into MELD

1 reference

7 January 2021

Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone

1 reference

7 January 2021

Hyponatremia Impairs Early Posttransplantation Outcome in Patients With Cirrhosis Undergoing Liver Transplantation

1 reference

7 January 2021